Breaking news: 3 new cannabis laws just burst onto the scene

Tomorrow’s the last day to register for our Urgent Cannabis Investor Briefing, which we’re holding online this coming Wednesday, May 8. (Just click here once, and we’ll promptly email you instructions to attend.)

At the briefing, we will introduce the first-ever cannabis stock rankings, based on the Weiss Ratings.

We will name the three stocks at the top of our rankings right now.

Plus, we will explain our ranking-based strategy that spins off an average of $20,000 in spendable cash per month.

And the timing couldn’t be better.

In fact, just in the last few days, two states and the District of Columbia have proposed new laws that will greatly expand the scope, reach and profits of the cannabis industry.

In Illinois, Gov. J.B. Pritzker announced new legislation on Saturday, less than 48 hours ago.

It would allow marijuana possession for residents 21 and over, provide a $20-million low-interest loan program to promote business ownership, and expunge about 800,000 low-level drug convictions. Tax revenue from the state’s cannabis industry would be invested in communities that have been devastated by drugs.

Ohio is proposing a new measure that will expand medical marijuana access to about half the state’s population, or another 6 million people. It would add five more ailments to the list of qualifying conditions to get a medical marijuana card, including anxiety, autism spectrum disorder, and opioid addiction.

And District of Columbia Mayor Muriel E. Bowser has just announced legislation to legalize and regulate marijuana dispensaries in the nation’s capital, setting up a potential showdown with the federal government.

Right now, the laws in D.C. are mixed: Residents can grow small amounts, but they can’t buy it legally. What most irks the District’s politicians, however, is a quirk in federal laws that prevents them from collecting taxes on the industry.

The mayor is hell-bent on changing that. She says she wants to make sure D.C. can collect its “fair share” of the revenues.

The Right, the Wrong and the Riches

Politicians debate endlessly about the right and wrong of legalization:

Recreational marijuana runs into the most resistance, and for obvious reasons. Medical marijuana is far more widely accepted, also for obvious reasons. But what’s primarily driving this accelerating trend is the riches. With legalization …

Desperately needed money flows into city and state coffers from cannabis tax revenues …

Still more money flows into the local economy from the cannabis industry and new jobs, while …

Nationally, money from cannabis profits piles up in the brokerage accounts of investors.

Back in 2016, for example, when major legalization ballot initiatives passed in eight U.S. states, leading cannabis stocks doubled and tripled in value:

  • GW Pharmaceuticals shot up 228%.
  • KushCo Holdings jumped 252%.
  • And Corbus Pharmaceuticals skyrocketed 668%.

More recently, the same thing happened in Canada, as Ottawa began to seriously consider nationwide legalization and Canadian cannabis stocks went through the roof:

  • A leading grower, Canopy Growth, rose by 100%.
  • Cronos Group, a medical cannabis producer, jumped 121%.
  • And Tilray, a research and tech company, soared 398%.

But I have a word of warning. Contrary to what you may be hearing …

Making money in the cannabis
boom is NOT a no-brainer.

Like any investment, there are also pitfalls.

Many investors get stuck in thinly traded stocks that may be easy to buy but are almost impossible to sell.

Others rush in to buy precisely when it’s time to take profits and move on to the next opportunity.

Here are some basic steps to follow …

Step 1. Avoid illiquid cannabis stocks. As a basic rule of thumb, stick with stocks that boast average trading volume of 100,000 shares per day or more.

Step 2. Focus on innovative companies in the forefront of medical marijuana, already legal in 33 states. Legalization for recreational usage is far behind, and most of the companies that profit primarily from the recreational side are not nearly as promising. They also run counter to the views of most conservative voters and investors.

Step 3. Needless to say, don’t bet the farm on any one company. Diversify. Keep a fair amount of cash in reserve. And continue investing in other promising stock market sectors.

Step 4. Join us on Wednesday for our cannabis briefing. It’s free for our Weiss Ratings readers. But you do have to register by clicking here.

And tomorrow (Tuesday, May 7th) is your last day to do so.

Good luck and God bless!

Martin

About the Weiss Ratings Founder

Dr. Weiss is the founder of Weiss Ratings, the nation’s leading provider of 100% independent grades on stocks, mutual funds and financial institutions, as well as the world’s only ratings agency that grades cryptocurrencies. He founded his company in 1971, and thanks largely to his strict independence, has established a 50-year record of accuracy. Forbes called him “Mr. Independence.” The U.S. Government Accountability Office (GAO) reported that his insurance company ratings outperformed those of A.M. Best, S&P and Moody’s by at least three to one. And The Wall Street Journal reported that investors using the Weiss stock ratings could have made more money than those following the grades issued by Merrill Lynch, J.P. Morgan, Goldman Sachs, Standard & Poor’s and every other firm reviewed.

Top Tech Stocks
See All »
B
MSFT NASDAQ $389.33
B
AAPL NASDAQ $169.30
B
NVDA NASDAQ $864.02
Top Consumer Staple Stocks
See All »
B
WMT NYSE $60.14
Top Financial Stocks
See All »
B
B
BRKA NYSE $606,920.00
B
V NYSE $271.37
Top Energy Stocks
See All »
B
B
CVX NYSE $161.27
B
COP NYSE $127.81
Top Health Care Stocks
See All »
B
AMGN NASDAQ $269.98
B
SYK NYSE $327.68
Top Real Estate Stocks
See All »
Weiss Ratings